Cerebricon Ltd.

Cerebricon Limited is a privately owned and fully proprietary independent research laboratory performing preclinical in vitro and in vivo models of CNS disease.

Using its inherent expertise, as well as the latest in scientific methods and equipment, Cerebricon aspires to provide the highest quality and most cost-beneficial preclinical studies available globally.

Years in Operation: 7

Location: Kuopio, Finland (pop 91, 000)

Contact Information:

Microkatu 1
Kuopio, Finland
70210
Tel. +358 17 368 0801
Fax +358 17 368 0803

E-mail enquiries (including career enquiries) info@cerebricon.com

Number of Staff: 30

Staff Breakdown:

Full-time Laboratory Personnel:

In vivo Scientists/Surgeons 6
Senior Technicians 5
Junior Technicians 3
Pharmacologists 4
Cell Biologists 3
Behavioural Scientists 2
In vitro Scientists 1
In vitro Technicians 1
Electrophysiologists 1

Other Services Offered:

Histology Services
Behavioral Phenotype Services
Neurological (dedicated) Preclinical Imaging Services
MRI/MRS/Spect/Pet/Micro CT
Electrophysiology


News:

7.6.2010
Charles River to Exhibit at the FELASA Helsinki, Finland June 14th-17th, 2010

7.6.2010
Meet Us at This Year’s FENS – 7th FORUM OF EUROPEAN NEUROSCIENCES

11.12.2009
Cerebricon Announces changes to Contact Details

2.9.2009
Cerebricon to Exhibit at the SFN 39th Annual Meeting in Chicago IL.

26.8.2009
Cerebricon Ltd Becomes Part of the Charles River Laboratories Family